Thomas Russo
Director of Finance/CFO chez ICOSAVAX, INC.
Profil
Thomas J.
Russo is currently the Chief Financial Officer at Icosavax, Inc. He previously worked as the Vice President & Head-Commercial Finance at Gilead Sciences, Inc. from 2012 to 2019, and as a Senior Research Analyst at Robert W.
Baird & Co., Inc. from 2004 to 2012.
He also served as the Chief Financial & Accounting Officer at Assembly Biosciences, Inc. from 2019 to 2021.
Russo received his undergraduate degree from the University of Notre Dame and his MBA from The University of Chicago Booth School of Business.
Postes actifs de Thomas Russo
Sociétés | Poste | Début |
---|---|---|
ICOSAVAX, INC. | Director of Finance/CFO | 01/06/2021 |
Anciens postes connus de Thomas Russo
Sociétés | Poste | Fin |
---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Director of Finance/CFO | 04/06/2021 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2019 |
Robert W. Baird & Co., Inc. (Broker)
Robert W. Baird & Co., Inc. (Broker) Investment Banks/BrokersFinance Robert W. Baird & Co., Inc. (Broker) (Baird-Broker) is the broker-dealer division of Robert W. Baird & Co., Inc., an investment bank and financial services company headquartered in Milwaukee, Wisconsin. The firm was founded in 1919 and is ultimately owned by Baird Financial Group, Inc. Baird-Broker offers a full suite of comprehensive trading services for institutional clients. | Analyst-Equity | 01/10/2012 |
Formation de Thomas Russo
University of Notre Dame | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Robert W. Baird & Co., Inc. (Broker)
Robert W. Baird & Co., Inc. (Broker) Investment Banks/BrokersFinance Robert W. Baird & Co., Inc. (Broker) (Baird-Broker) is the broker-dealer division of Robert W. Baird & Co., Inc., an investment bank and financial services company headquartered in Milwaukee, Wisconsin. The firm was founded in 1919 and is ultimately owned by Baird Financial Group, Inc. Baird-Broker offers a full suite of comprehensive trading services for institutional clients. | Finance |
Icosavax, Inc.
Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |